Bing Kan
Impact in
- Molecular Medicine top 5%
- Hydrogels: synthesis, properties, applications
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
Papers in
-
- RNA Interference and Gene Delivery 11
- Angiogenesis and VEGF in Cancer 7
- Glycosylation and Glycoproteins Research 4
- Biomaterials 11
- biodegradable polymer synthesis and properties 7
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Yuquan Wei (16 shared papers)Xia Zhao (6 shared papers)Feng Luo (9 shared papers)Mei Dai (6 shared papers)Zhiyong Qian (12 shared papers)Maling Gou (5 shared papers)Yongsheng Wang (6 shared papers)Xiancheng Chen (6 shared papers)
- Journals
- Drug Delivery (2 papers)International Journal of Pharmaceutics (2 papers)Journal of Biomedical Materials Research Part A (2 papers)Anti-Cancer Drugs (2 papers)Journal of Materials Science Materials in Medicine (2 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Bing Kan
47 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Molecular Medicine 153
- Biomaterials 355
- Pharmaceutical Science 135
- Drug Discovery 2
- Genetics 111
Countries citing papers authored by Bing Kan
This map shows the geographic impact of Bing Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Kan more than expected).
Fields of papers citing papers by Bing Kan
This network shows the impact of papers produced by Bing Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Kan. The network helps show where Bing Kan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 141 | |
| 2 | 2009 | 108 | |
| 3 | 2003 | 98 | |
| 4 | 2007 | 71 | |
| 5 | 2008 | 64 | |
| 6 | 2008 | 57 | |
| 7 | 2007 | 57 | |
| 8 | Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. | 2003 | 53 |
| 9 | 2007 | 44 | |
| 10 | 2011 | 39 | |
| 11 | 2008 | 38 | |
| 12 | 2013 | 28 | |
| 13 | 2005 | 25 | |
| 14 | 2009 | 25 | |
| 15 | 2008 | 24 | |
| 16 | 2009 | 24 | |
| 17 | 2013 | 24 | |
| 18 | 2005 | 24 | |
| 19 | 2008 | 23 | |
| 20 | 2006 | 22 |
About Bing Kan
Bing Kan is a scholar working on Molecular Biology, Biomaterials, Immunology, Oncology and Organic Chemistry, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Angiogenesis and VEGF in Cancer (7 papers), Immunotherapy and Immune Responses (7 papers), biodegradable polymer synthesis and properties (7 papers), Nanoparticle-Based Drug Delivery (5 papers), Glycosylation and Glycoproteins Research (4 papers), Cancer Research and Treatments (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Molecular Medicine (153 citations), Biomaterials (355 citations), Pharmaceutical Science (135 citations), Drug Discovery (2 citations) and Genetics (111 citations). Bing Kan has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Yuquan Wei, Xia Zhao, Feng Luo, Mei Dai, Zhiyong Qian, Maling Gou, Yongsheng Wang, Xiancheng Chen, Zhi Yong Qian and Ma Ling Gou. Their work appears in journals such as Drug Delivery, International Journal of Pharmaceutics, Journal of Biomedical Materials Research Part A, Anti-Cancer Drugs and Journal of Materials Science Materials in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.